Elevated levels of IL-17 have been observed in the CSF and serum of MS cases [25], and during clinical exacerbations, higher levels of IL-17 mRNA were also detected in the CSF relative to that in the blood [26]. Here, IL17A is linked to myeloid sarcoma.